Amylyx Pharmaceuticals, Inc. - COM (AMLX)

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Equity / COM
Number of holders
72
Total Shares
23.4M
Shares change
+23.4M
Total reported value, excl. options
$300M
Value change
+$300M
Put/Call ratio
0.09
Number of buys
71
Number of sells
0
Price
$12.85
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.